Because pan-PIM kinase inhibition did not significantly reduce cell proliferation, although it clearly abrogated PIM activity as assessed by BAD phosphorylation, it can be hypothesised that PIM2 might have kinase-independent functions in DLBCL and BL. The gene discussed is PIM1; the disease is Burkitt lymphoma.